Anna Marie Wagner is the Founder and CEO of a stealth biotechnology company, leveraging artificial intelligence to drive more efficient experimentation. Her career has spanned investing and operating roles in both hypergrowth and mature companies. She brings a unique breadth of experience, having served as a hands-on executive leading multiple strategic functions across industries, particularly technology and life sciences. She currently advises companies across both the public and private sectors. Previously, Anna Marie was on the executive team at Ginkgo Bioworks (NYSE:DNA), where over the years she built and led numerous functions including finance, corporate development, and AI. Anna Marie led Ginkgo’s public offering in 2021, raising $1.6 billion in what is still the largest-ever go-public raise in biotech. She is also an Executive Fellow at Harvard Business School, where she co-teaches an elective course on failure (and loves the irony!).